KP Tissue Inc. (TSE:KPT – Get Free Report) shares passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of C$11.46 and traded as high as C$12.92. KP Tissue shares last traded at C$12.82, with a volume of 28,347 shares changing hands.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the stock. TD upped their price target on shares of KP Tissue from C$12.00 to C$14.00 and gave the stock a “hold” rating in a research note on Tuesday, July 14th. Desjardins raised their price objective on shares of KP Tissue from C$12.00 to C$12.50 and gave the company a “hold” rating in a research note on Friday, May 15th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, KP Tissue presently has an average rating of “Hold” and an average target price of C$12.12.
Read Our Latest Report on KP Tissue
KP Tissue Stock Down 0.1%
KP Tissue (TSE:KPT – Get Free Report) last posted its quarterly earnings results on Thursday, May 14th. The company reported C$0.22 earnings per share (EPS) for the quarter. On average, sell-side analysts predict that KP Tissue Inc. will post 0.4398964 earnings per share for the current year.
KP Tissue Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 15th were issued a dividend of $0.21 per share. The ex-dividend date was Tuesday, June 30th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 6.6%. KP Tissue’s payout ratio is currently 80.00%.
Insider Activity
In other news, Director David A. Spraley sold 3,668 shares of the stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of C$13.30, for a total value of C$48,784.40. Following the completion of the sale, the director directly owned 15,712 shares of the company’s stock, valued at C$208,969.60. This represents a 18.93% decrease in their ownership of the stock. Insiders have sold 6,668 shares of company stock valued at $87,644 over the last ninety days. 0.14% of the stock is owned by corporate insiders.
About KP Tissue
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Featured Articles
- Five stocks we like better than KP Tissue
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
